Literature DB >> 22644161

Allodynia and migraine.

Marco Aguggia1.   

Abstract

An impaired processing of sensory afferents in the brainstem plays a key role in the development of migraine attack and for many of its clinical aspects. The repetition or prolonged of painful stimuli over time would be able to produce a prolonged and reversible increase of excitability and synaptic efficacy in the nociceptive pathways of the central nervous system. This phenomenon, known as sensitization, involves specifically the caudal trigeminal nucleus. Being an aspect of untreated migraine, allodynia is more common in patients with chronic migraine and migraine with aura, often associated with motor and sensory symptoms sometimes present during the attacks. The presence of allodynia in the course of migraine attack greatly increases the disability of the patient and its recognition, as well as from a therapeutic point of view, it is essential in the management of migraine patients.

Entities:  

Mesh:

Year:  2012        PMID: 22644161     DOI: 10.1007/s10072-012-1034-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

1.  Protein Kinase C γ Contributes to Central Sensitization in a Rat Model of Chronic Migraine.

Authors:  Baixue Wu; Sha Wang; Guangcheng Qin; Jingmei Xie; Ge Tan; Jiying Zhou; Lixue Chen
Journal:  J Mol Neurosci       Date:  2017-08-25       Impact factor: 3.444

2.  Identification of Allodynic Migraine Patients with the Turkish Version of the Allodynia Symptom Checklist: Reliability and Consistency Study.

Authors:  Osman Özgür Yalin; Derya Uludüz; Mehmet Ali Sungur; Hande Sart; Aynur Özge
Journal:  Noro Psikiyatr Ars       Date:  2016-04-15       Impact factor: 1.339

3.  The association between migraine and hospital readmission due to pain after surgery: A hospital registry study.

Authors:  Katharina Platzbecker; Megan Behua Zhang; Tobias Kurth; Maira Isabella Rudolph; Katharina Eikermann-Haerter; Rami Burstein; Matthias Eikermann; Timothy Houle
Journal:  Cephalalgia       Date:  2018-07-08       Impact factor: 6.292

4.  Blockade of Nav1.8 currents in nociceptive trigeminal neurons contributes to anti-trigeminovascular nociceptive effect of amitriptyline.

Authors:  Jingyao Liang; Xiaoyan Liu; Meiyan Pan; Wei Dai; Zhao Dong; Xiaolin Wang; Ruozhuo Liu; Jianquan Zheng; Shengyuan Yu
Journal:  Neuromolecular Med       Date:  2013-11-30       Impact factor: 3.843

5.  Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

Authors:  Ram Kandasamy; Cole T Dawson; Rebecca M Craft; Michael M Morgan
Journal:  Eur J Pharmacol       Date:  2017-10-28       Impact factor: 4.432

6.  Altered effective connectivity of posterior thalamus in migraine with cutaneous allodynia: a resting-state fMRI study with Granger causality analysis.

Authors:  Ting Wang; Ning Chen; Wang Zhan; Jia Liu; Junpeng Zhang; Qi Liu; Hua Huang; Li He; Junran Zhang; Qiyong Gong
Journal:  J Headache Pain       Date:  2016-02-27       Impact factor: 7.277

7.  Blink reflex in migraine headache.

Authors:  Zeynep Unal; Fusun Mayda Domac; Ece Boylu; Abdulkadir Kocer; Tulin Tanridag; Onder Us
Journal:  North Clin Istanb       Date:  2016-04-26

8.  Depression of home cage wheel running: a reliable and clinically relevant method to assess migraine pain in rats.

Authors:  Ram Kandasamy; Andrea T Lee; Michael M Morgan
Journal:  J Headache Pain       Date:  2017-01-13       Impact factor: 7.277

9.  Upper cervical two-point discrimination thresholds in migraine patients and headache-free controls.

Authors:  Kerstin Luedtke; Waclaw Adamczyk; Katrin Mehrtens; Inken Moeller; Louisa Rosenbaum; Axel Schaefer; Janine Schroeder; Tibor Szikszay; Christian Zimmer; Bettina Wollesen
Journal:  J Headache Pain       Date:  2018-06-26       Impact factor: 7.277

10.  Clinical observation of the effect of prophylaxis on allodynia in patients with migraine.

Authors:  Na Zhang; Chun-Fu Chen
Journal:  J Pain Res       Date:  2018-11-02       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.